Ftse Mib
35.090,23
-0,64%
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
-1,63%
Bitcoin
94.322,04
-0,41%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tenax Therapeutics Inc (TENX) Tenax Therapeutics Inc (TENX) Notizie

Tenax Therapeutics Inc

TENX
6,24
-0,24 (-3,70%)
10 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/1/202522:27EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/12/202402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202401:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202422:54EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/12/202423:16EDGAR2Form 8-K - Current report
26/11/202422:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/11/202401:14EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
14/11/202418:39EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202418:21EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202423:35EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202422:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202414:15EDGAR2Form 8-K - Current report
12/11/202415:32EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
31/10/202421:05GLOBETenax Therapeutics to Present at the Guggenheim Healthcare..
30/10/202421:32EDGAR2Form 8-K - Current report
27/9/202414:14EDGAR2Form DEF 14A - Other definitive proxy statements
10/9/202423:19EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
20/8/202400:48EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
19/8/202422:15EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
15/8/202422:19EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
15/8/202400:47EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
13/8/202422:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202422:30EDGAR2Form 8-K - Current report
12/8/202414:35EDGAR2Form 8-K - Current report
09/8/202401:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202401:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202422:55APSBiotech Soars Following Oversubscribed $100M Private..
06/8/202413:23EDGAR2Form 8-K - Current report
13/6/202422:32EDGAR2Form 8-K - Current report
21/5/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202415:01EDGAR2Form 8-K - Current report
14/5/202414:00GLOBETenax Therapeutics Reports First Quarter 2024 Financial..
30/4/202413:30GLOBETenax Therapeutics Announces New U.S. Patent Covering the..
09/4/202414:30GLOBETenax Therapeutics to Host KOL Event: “LEVEL Setting: the..
28/3/202413:30GLOBETenax Therapeutics Provides Business and Clinical..
12/3/202413:30GLOBETenax Therapeutics to Present at the 36th Annual Roth..
29/2/202415:00GLOBETenax Therapeutics Announces Oral Presentation of..
23/2/202422:30EDGAR2Form 8-K - Current report
20/2/202422:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
20/2/202414:33EDGAR2Form 8-K - Current report
20/2/202414:30GLOBETenax Therapeutics Announces Global License Amendment that..
16/2/202417:28EDGAR2Form SC 13G - Statement of acquisition of beneficial..
16/2/202401:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
Apertura: 6,53 Min: 6,1642 Max: 6,53
Chiusura: 6,48

La tua Cronologia

NASDAQ
TENX
Tenax Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network